TT3A is an innovative Italy-based MedTech startup pioneering the development of the world’s first medical device for the endovascular treatment of ascending aortic aneurysms and dissections. Currently advancing into the pre-clinical phase, we aim to demonstrate in-vivo feasibility, efficacy, and sa... Read more
This company has no teams yet
This company has no offices yet